Customized, or randomized approach for H3K27M mutated diffuse midline gliomas? Analysis of 13 biopsy proven patients from two countries
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Conference abstract |
| Citation |
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Conference abstract |
| Citation |